- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Immunotoxins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Immunotoxinsmarket, defines the market attractiveness level of Immunotoxins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Immunotoxins industry, describes the types of Immunotoxins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immunotoxins market and the development prospects and opportunities of Immunotoxins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immunotoxins market in Chapter 13.
By Player:
Amgen
Research Corporation Technologies
Neurocrine Biosciences
Genentech
AREVA Med
Bayer HealthCare
Celldex Therapeutics
CuraGen Corporation
Genmab
Biotest
By Type:
Anthrax Based Toxins
Diphtheria Toxin (DT) & DT Derivatives
Pseudomonas Exotoxin (PE) & PE Derivatives
Ribosome Inactivating Proteins Based Immunotoxins
Ribonucleases based Immunotoxins
Others
By End-User:
Solid Tumors
Leukemias
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Immunotoxins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Immunotoxins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Immunotoxins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Immunotoxins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Immunotoxins Market Analysis and Outlook to 2022
-
7.1 Global Immunotoxins Consumption (2017-2022)
-
7.2 United States Immunotoxins Consumption (2017-2022)
-
7.3 Europe Immunotoxins Consumption (2017-2022)
-
7.4 China Immunotoxins Consumption (2017-2022)
-
7.5 Japan Immunotoxins Consumption (2017-2022)
-
7.6 India Immunotoxins Consumption (2017-2022)
-
7.7 South Korea Immunotoxins Consumption (2017-2022)
8 Region and Country-wise Immunotoxins Market Analysis and Outlook to 2028
-
8.1 Global Immunotoxins Consumption Forecast (2022-2028)
-
8.2 United States Immunotoxins Consumption Forecast (2022-2028)
-
8.3 Europe Immunotoxins Consumption Forecast (2022-2028)
-
8.4 China Immunotoxins Consumption Forecast (2022-2028)
-
8.5 Japan Immunotoxins Consumption Forecast (2022-2028)
-
8.6 India Immunotoxins Consumption Forecast (2022-2028)
-
8.7 South Korea Immunotoxins Consumption Forecast (2022-2028)
9 Global Immunotoxins Market Outlook by Types and Applications to 2022
-
9.1 Global Immunotoxins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anthrax Based Toxins Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diphtheria Toxin (DT) & DT Derivatives Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pseudomonas Exotoxin (PE) & PE Derivatives Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ribosome Inactivating Proteins Based Immunotoxins Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Ribonucleases based Immunotoxins Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Immunotoxins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Leukemias Consumption and Growth Rate (2017-2022)
10 Global Immunotoxins Market Outlook by Types and Applications to 2028
-
10.1 Global Immunotoxins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anthrax Based Toxins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diphtheria Toxin (DT) & DT Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pseudomonas Exotoxin (PE) & PE Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ribosome Inactivating Proteins Based Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Ribonucleases based Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Immunotoxins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Leukemias Consumption Forecast and Growth Rate (2022-2028)
11 Global Immunotoxins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Immunotoxins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Immunotoxins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Immunotoxins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Immunotoxins Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Immunotoxins Product and Service
-
14.2 Research Corporation Technologies
-
14.2.1 Research Corporation Technologies Company Details
-
14.2.2 Research Corporation Technologies Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Research Corporation Technologies Immunotoxins Product and Service
-
14.3 Neurocrine Biosciences
-
14.3.1 Neurocrine Biosciences Company Details
-
14.3.2 Neurocrine Biosciences Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Neurocrine Biosciences Immunotoxins Product and Service
-
14.4 Genentech
-
14.4.1 Genentech Company Details
-
14.4.2 Genentech Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genentech Immunotoxins Product and Service
-
14.5 AREVA Med
-
14.5.1 AREVA Med Company Details
-
14.5.2 AREVA Med Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AREVA Med Immunotoxins Product and Service
-
14.6 Bayer HealthCare
-
14.6.1 Bayer HealthCare Company Details
-
14.6.2 Bayer HealthCare Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer HealthCare Immunotoxins Product and Service
-
14.7 Celldex Therapeutics
-
14.7.1 Celldex Therapeutics Company Details
-
14.7.2 Celldex Therapeutics Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Celldex Therapeutics Immunotoxins Product and Service
-
14.8 CuraGen Corporation
-
14.8.1 CuraGen Corporation Company Details
-
14.8.2 CuraGen Corporation Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 CuraGen Corporation Immunotoxins Product and Service
-
14.9 Genmab
-
14.9.1 Genmab Company Details
-
14.9.2 Genmab Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Genmab Immunotoxins Product and Service
-
14.10 Biotest
-
14.10.1 Biotest Company Details
-
14.10.2 Biotest Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Biotest Immunotoxins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Immunotoxins
-
Figure Immunotoxins Picture
-
Table Global Immunotoxins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotoxins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Immunotoxins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Immunotoxins Consumption by Country (2017-2022)
-
Figure United States Immunotoxins Consumption and Growth Rate (2017-2022)
-
Table Europe Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure China Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure Japan Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure India Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotoxins Consumption Forecast by Country (2022-2028)
-
Figure United States Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anthrax Based Toxins Consumption and Growth Rate (2017-2022)
-
Figure Global Diphtheria Toxin (DT) & DT Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global Pseudomonas Exotoxin (PE) & PE Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global Ribosome Inactivating Proteins Based Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure Global Ribonucleases based Immunotoxins Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemias Consumption and Growth Rate (2017-2022)
-
Figure Global Anthrax Based Toxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diphtheria Toxin (DT) & DT Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pseudomonas Exotoxin (PE) & PE Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ribosome Inactivating Proteins Based Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ribonucleases based Immunotoxins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemias Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Immunotoxins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Immunotoxins Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Immunotoxins Product and Service
-
Table Research Corporation Technologies (Foundation Year, Company Profile and etc.)
-
Table Research Corporation Technologies Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Research Corporation Technologies Immunotoxins Product and Service
-
Table Neurocrine Biosciences (Foundation Year, Company Profile and etc.)
-
Table Neurocrine Biosciences Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurocrine Biosciences Immunotoxins Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Immunotoxins Product and Service
-
Table AREVA Med (Foundation Year, Company Profile and etc.)
-
Table AREVA Med Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table AREVA Med Immunotoxins Product and Service
-
Table Bayer HealthCare (Foundation Year, Company Profile and etc.)
-
Table Bayer HealthCare Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer HealthCare Immunotoxins Product and Service
-
Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celldex Therapeutics Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celldex Therapeutics Immunotoxins Product and Service
-
Table CuraGen Corporation (Foundation Year, Company Profile and etc.)
-
Table CuraGen Corporation Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CuraGen Corporation Immunotoxins Product and Service
-
Table Genmab (Foundation Year, Company Profile and etc.)
-
Table Genmab Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Immunotoxins Product and Service
-
Table Biotest (Foundation Year, Company Profile and etc.)
-
Table Biotest Immunotoxins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Immunotoxins Product and Service
-